Josep Maria Rojo

Unit:

Cancer Science

Position:

Alumni - Postdoctoral Fellow

Office:

EM01B11-12

Telephone:

+34 93 40 37096

Email:

pep.rojo@irbbarcelona.org

Left IRB Barcelona in March 2025

Research Group

Research Unit on Asymmetric Synthesis

Cancer Science

Selected group publications

Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation

Donoghue, C; Cubillos-Rojas, M; Gutierrez-Prat, N; Sanchez-Zarzalejo, C; Verdaguer, X; Riera, A; Nebreda, AR

European Journal Of Medicinal Chemistry

201

(- )

112451 -

(2020)

Synthesis and Application of 3-Bromo-1,2,4,5-Tetrazine for Protein Labeling to Trigger Click-to-Release Biorthogonal Reactions

Ros, E; Bellido, M; Verdaguer, X; de Pouplana, LR; Riera, A

Bioconjugate Chemistry

(3 )

933 -

938

(2020)

P-Stereogenic Amino-Phosphines as Chiral Ligands: From Privileged Intermediates to Asymmetric Catalysis

Cabré, A; Riera, A; Verdaguer, X

Accounts Of Chemical Research

(3 )

676 -

689

(2020)

Recent Advances in the Enantioselective Synthesis of Chiral Amines via Transition Metal-Catalyzed Asymmetric Hydrogenation

Cabré, A; Verdaguer, X; Riera, A

Chemical Reviews

122

(1 )

269 -

339

(2022)

Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease

Rol, A; Todorovski, T; Martin-Malpartida, P; Escolà, A; Gonzalez-Rey, E; Aragón, E; Verdaguer, X; Vallès-Miret, M; Farrera-Sinfreu, J; Puig, E; Fernández-Carneado, J; Ponsati, B; Delgado, M; Riera, A; Macias, MJ

Nature Communications

(1 )

1869 -

(2021)

Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation

Donoghue, C; Cubillos-Rojas, M; Gutierrez-Prat, N; Sanchez-Zarzalejo, C; Verdaguer, X; Riera, A; Nebreda, AR

European Journal Of Medicinal Chemistry

201

(- )

112451 -

(2020)

Synthesis and Application of 3-Bromo-1,2,4,5-Tetrazine for Protein Labeling to Trigger Click-to-Release Biorthogonal Reactions

Ros, E; Bellido, M; Verdaguer, X; de Pouplana, LR; Riera, A

Bioconjugate Chemistry

(3 )

933 -

938

(2020)

P-Stereogenic Amino-Phosphines as Chiral Ligands: From Privileged Intermediates to Asymmetric Catalysis

Cabré, A; Riera, A; Verdaguer, X

Accounts Of Chemical Research

(3 )

676 -

689

(2020)

Recent Advances in the Enantioselective Synthesis of Chiral Amines via Transition Metal-Catalyzed Asymmetric Hydrogenation

Cabré, A; Verdaguer, X; Riera, A

Chemical Reviews

122

(1 )

269 -

339

(2022)

Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease

Nature Communications

(1 )

1869 -

(2021)

Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation

Donoghue, C; Cubillos-Rojas, M; Gutierrez-Prat, N; Sanchez-Zarzalejo, C; Verdaguer, X; Riera, A; Nebreda, AR

European Journal Of Medicinal Chemistry

201

(- )

112451 -

(2020)

Dr. Josep Maria Rojo